Person: John Climax

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Icon puts in strong Q2 performance

IRISH medical device and pharmaceutical services specialist, Icon, has followed up a solid set of first-quarter figures with an equally strong second-quarter showing.

business

ICON shares up 4% on profit leap

business

Amarin buys Israeli firm in €22m deal

business

Markets buoyed by Icon growth

business

Icon announces revenues boost, Dublin facility sale plan

business

Record business worth at ICON

Icon Q1 revenues up 10%

ISEQ and Nasdaq-listed technology company Icon reported Q1 revenues for fiscal 2006 up 10% at $85.9m (€71.5m).

Tue, 27 Sep, 2005

Icon Q4 revenues jump to €71.7m

SHARES in Icon jumped 6% yesterday after the Dublin-based clinical research company reported strong fourth-quarter figures.

Wed, 03 Aug, 2005

€8.6m once-off charges hit Icon

CLINICAL research firm Icon had a once-off hit of $11.3 million (€8.6m) to blame for sending its third-quarter results into the red yesterday.

Thu, 31 Mar, 2005

ICON revenues climb 8% to $82.9m for Q3

Global contract clinical research organisation ICON today reported revenues up 8% to $82.9m (€63.8m) for its third quarter ended February 28, 2005.

Wed, 30 Mar, 2005

Icon shares tumble 5% as full-year forecast cut

SHARES in Icon fell 5% on New York’s NASDAQ yesterday after the Dublin-based clinical research group reported lower second quarter profits and cut its full-year forecasts.

Fri, 07 Jan, 2005

Icon profits down $500,000

ISEQ-listed clinical research group Icon has reported 2004 second quarter net profits of $5.8m (€4.4m), compared with $6.3m (€4.8m) in the same quarter in 2003.

Thu, 06 Jan, 2005

Icon toast profits increase, but issue note of caution

Contract clinical research company Icon has announced a 14% increase in net revenues for the first quarter.

Tue, 28 Sep, 2004

Icon loses 22% of value after predictions of slow revenue growth

ICON, the Nasdaq-listed Irish clinical research group, lost 22% of its value at one stage yesterday after warning that revenue growth would be slower than expected.

Wed, 28 Jul, 2004

ICON Q3 profits surge by 42% to $8.8m

ICON, the listed clinical trials company, has reported a 42% surge in third quarter pre-tax profits helped by a strong pipeline of new business wins.

Fri, 02 Apr, 2004

Icon Q3 report shows positive results

A 30% increase in quarterly revenues and strong growth in income from operations left Icon representatives in buoyant humour today.

Thu, 01 Apr, 2004

Strong revenue growth for ICON in Q2

Clinical research organisation ICON saw Q2 net revenues increase by 37% to $73.2m (€57.49m) with income from operations up 33% over the same period to $8.4m (€6.59m).

Tue, 13 Jan, 2004

Top earners on rich list despite ritzy weddings

PLUSH weddings failed to stop high-flying businessman Michael O’Leary and Westlife star Nicky Byrne from being among the country’s top earners in the past year.

Mon, 03 Nov, 2003

47% revenue increase reported by ICON

Pharmaceutical giant ICON has reported a 47% increase in net revenues to $68.9m (€58.9m) in its Q1 earnings to end August 2003.

Tue, 30 Sep, 2003